ABBV

The Hepatitis C Cure Poised to Break the Country

moreView todays social media effects on ABBVView the latest stocks trending across Twitter. Click to view dashboardSee who AbbVie is hiring next, click here to view […]

Merck Shouts Me, Too! But Will It Matter?

moreView todays social media effects on ABBVView the latest stocks trending across Twitter. Click to view dashboardSee who AbbVie is hiring next, click here to view […]

AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congressâ„¢

[PR Newswire] – LONDON, April 12, 2014 /PRNewswire/ — AbbVie (NYSE:ABBV) announced that new, detailed results from its hepatitis C development program will be presented today at the International Liver Congress TM (ILC) … moreView todays social media effects on ABBVView the latest stocks trending across Twitter. Click to view dashboardSee who AbbVie is hiring next, click here to view […]

Zogenix files lawsuit against Massachusetts over painkiller ban

[Reuters] – Zogenix Inc said it sought a restraining order against an order by Massachusetts officials blocking sales of its FDA-approved painkiller, Zohydro. Massachusetts Governor Deval Patrick announced the Zohydro ban in late March, formally declarin moreView todays social media effects on ABBVView the latest stocks trending across Twitter. Click to view dashboardSee who AbbVie is hiring next, click here […]

Dividend Derby: AbbVie Vs. Pfizer

moreView todays social media effects on ABBVView the latest stocks trending across Twitter. Click to view dashboardSee who AbbVie is hiring next, click here to view […]

Ranking Big Pharma’s Top Drugs of 2013

moreView todays social media effects on ABBVView the latest stocks trending across Twitter. Click to view dashboardSee who AbbVie is hiring next, click here to view […]